BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20224240)

  • 1. An updated nation-wide epidemiological survey of feline immunodeficiency virus (FIV) infection in Japan.
    Nakamura Y; Nakamura Y; Ura A; Hirata M; Sakuma M; Sakata Y; Nishigaki K; Tsujimoto H; Setoguchi A; Endo Y
    J Vet Med Sci; 2010 Aug; 72(8):1051-6. PubMed ID: 20224240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic subtyping and epidemiological study of feline immunodeficiency virus by nested polymerase chain reaction-restriction fragment length polymorphism analysis of the gag gene.
    Hohdatsu T; Motokawa K; Usami M; Amioka M; Okada S; Koyama H
    J Virol Methods; 1998 Jan; 70(1):107-11. PubMed ID: 9506819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of feline calicivirus, feline immunodeficiency virus, feline leukemia virus, feline herpesvirus and Bartonella henselae in cats with chronic gingivostomatitis.
    Belgard S; Truyen U; Thibault JC; Sauter-Louis C; Hartmann K
    Berl Munch Tierarztl Wochenschr; 2010; 123(9-10):369-76. PubMed ID: 21038808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from the cat: development of vaccines against lentiviruses.
    Dunham SP
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):67-77. PubMed ID: 16678276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feline immunodeficiency virus: a concise review.
    Kanzaki LI; Looney DJ
    Front Biosci; 2004 Jan; 9():370-7. PubMed ID: 14766374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk analysis of feline immunodeficiency virus infection in Tsushima leopard cats (Prionailurus bengalensis euptilurus) and domestic cats using a geographic information system.
    Hayama S; Yamamoto H; Nakanishi S; Hiyama T; Murayama A; Mori H; Sugitani A; Fujiwara S
    J Vet Med Sci; 2010 Sep; 72(9):1113-8. PubMed ID: 20379084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior virus exposure alters the long-term landscape of viral replication during feline lentiviral infection.
    Zheng X; Carver S; Troyer RM; Terwee JA; VandeWoude S
    Viruses; 2011 Oct; 3(10):1891-908. PubMed ID: 22069521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phylogenetic study of Feline Immunodeficiency Virus (FIV) among domestic cats in Turkey.
    Koç BT; Oğuzoğlu TÇ
    Comp Immunol Microbiol Infect Dis; 2020 Dec; 73():101544. PubMed ID: 32911378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats.
    Kusuhara H; Hohdatsu T; Seta T; Nemoto K; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
    Vet Microbiol; 2007 Mar; 120(3-4):217-25. PubMed ID: 17141431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
    Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
    Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feline immunodeficiency virus (FIV) neutralization: a review.
    Hosie MJ; Pajek D; Samman A; Willett BJ
    Viruses; 2011 Oct; 3(10):1870-90. PubMed ID: 22069520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of feline immunodeficiency virus in the domestic cat (Felis catus).
    Hayward JJ; Rodrigo AG
    Vet Immunol Immunopathol; 2010 Mar; 134(1-2):68-74. PubMed ID: 19896220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of antibody response following vaccination against feline immunodeficiency virus.
    Westman ME; Malik R; Hall E; Harris M; Hosie MJ; Norris JM
    J Feline Med Surg; 2017 Oct; 19(10):1055-1064. PubMed ID: 27770018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns.
    Sodora DL; Shpaer EG; Kitchell BE; Dow SW; Hoover EA; Mullins JI
    J Virol; 1994 Apr; 68(4):2230-8. PubMed ID: 8139008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phylogenetic characterisation of feline immunodeficiency virus in naturally infected cats in Croatia indicates additional heterogeneity of subtype B in Europe.
    Perharić M; Biđin M; Starešina V; Milas Z; Turk N; Štritof Z; Hađina S; Habuš J; Stevanović V; Mojčec-Perko V; Kovač S; Martinković K; Barbić L
    Arch Virol; 2016 Sep; 161(9):2567-73. PubMed ID: 27318929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of Toxoplasma gondii and concurrent Bartonella spp., feline immunodeficiency virus, feline leukemia virus, and Dirofilaria immitis infections in Egyptian cats.
    Al-Kappany YM; Lappin MR; Kwok OC; Abu-Elwafa SA; Hilali M; Dubey JP
    J Parasitol; 2011 Apr; 97(2):256-8. PubMed ID: 21506874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological survey of Toxoplasma gondii, Dirofilaria immitis, Feline Immunodeficiency Virus (FIV) and Feline Leukemia Virus (FeLV) infections in pet cats in Bangkok and vicinities, Thailand.
    Sukhumavasi W; Bellosa ML; Lucio-Forster A; Liotta JL; Lee AC; Pornmingmas P; Chungpivat S; Mohammed HO; Lorentzen L; Dubey JP; Bowman DD
    Vet Parasitol; 2012 Aug; 188(1-2):25-30. PubMed ID: 22497870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characteristics of malignant lymphomas in cats naturally infected with feline immunodeficiency virus.
    Endo Y; Cho KW; Nishigaki K; Momoi Y; Nishimura Y; Mizuno T; Goto Y; Watari T; Tsujimoto H; Hasegawa A
    Vet Immunol Immunopathol; 1997 Jul; 57(3-4):153-67. PubMed ID: 9261955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
    Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
    Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge.
    Huang C; Conlee D; Gill M; Chu HJ
    J Feline Med Surg; 2010 Jun; 12(6):451-7. PubMed ID: 20167521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.